SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $133,000 | -0.7% | 27,142 | -16.3% | 0.01% | -13.3% |
| Q2 2022 | $134,000 | -70.5% | 32,423 | -58.6% | 0.02% | -72.2% |
| Q1 2022 | $455,000 | +78.4% | 78,376 | +267.4% | 0.05% | +107.7% |
| Q2 2021 | $255,000 | +44.9% | 21,331 | +8.7% | 0.03% | 0.0% |
| Q2 2020 | $176,000 | -69.3% | 19,628 | -51.4% | 0.03% | -69.8% |
| Q2 2018 | $573,000 | +102.5% | 40,384 | +171.0% | 0.09% | +104.8% |
| Q1 2018 | $283,000 | -70.3% | 14,901 | -76.5% | 0.04% | -72.9% |
| Q3 2017 | $953,000 | +1412.7% | 63,519 | +421.6% | 0.16% | +933.3% |
| Q1 2017 | $63,000 | – | 12,177 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |